Associate Professor, Schools of Pharmacy, University of Reading
I have been working on neurodegenerative diseases for over ten years, first at the Mayo Clinic in Florida where I worked on the molecular basis of Alzheimer’s disease. I then carried out graduate studies at the Medical Research Council Prion Unit at the UCL Institute of Neurology where I completed a PhD on the molecular characteristics of the Scrapie agent in 2005. I started working on Parkinson’s disease at the National Institute on Aging in Bethesda in the Laboratory of Neurogenetics under Mark Cookson. It was in Bethesda that I first came across Leucine Rich Repeat Kinase 2, LRRK2, a protein which I have been investigating ever since. In 2007 I returned to the UCL Institute of Neurology and the Department of Molecular Neuroscience.
Head, School of Biological, Biomedical and Environmental Sciences, University of Hull
Professor of Physics, Imperial College London
Professor of IT Ethics, University of Plymouth
Paralympian & Crossbench Peer
Peer & Former Cabinet Minister
Former Director of Porsche & BMW